Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion

OBJECTIVE: Understanding the price components of the mifepristone/misoprostol (combi-pack) for medical abortion to improve access is critical for identifying strategies to reduce product costs for quality-assured formulations and expanding its availability and use. METHODS: We constructed a cost of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinery, Lester, Allaouidine, Chadia, Tomazzini, Alessandra, Larson, Melanie, Gülmezoglu, A. Metin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640653/
https://www.ncbi.nlm.nih.gov/pubmed/33148282
http://dx.doi.org/10.1186/s12978-020-01012-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640653/
https://www.ncbi.nlm.nih.gov/pubmed/33148282
http://dx.doi.org/10.1186/s12978-020-01012-8

Ejemplares similares